Return on Investment in Disease Management: A Review

The results of 44 studies investigating financial impact and return on investment (ROI) from disease management (DM) programs for asthma, congestive heart failure (CHF), diabetes, depression, and multiple illnesses were examined. A positive ROI was found for programs directed at CHF and multiple dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Goetzel, Ron Z., Ozminkowski, Ronald J., Villagra, Victor G., Duffy, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CENTERS for MEDICARE & MEDICAID SERVICES 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194913/
https://www.ncbi.nlm.nih.gov/pubmed/17288065
_version_ 1782339213840089088
author Goetzel, Ron Z.
Ozminkowski, Ronald J.
Villagra, Victor G.
Duffy, Jennifer
author_facet Goetzel, Ron Z.
Ozminkowski, Ronald J.
Villagra, Victor G.
Duffy, Jennifer
author_sort Goetzel, Ron Z.
collection PubMed
description The results of 44 studies investigating financial impact and return on investment (ROI) from disease management (DM) programs for asthma, congestive heart failure (CHF), diabetes, depression, and multiple illnesses were examined. A positive ROI was found for programs directed at CHF and multiple disease conditions. Some evidence suggests that diabetes programs may save more than they cost, but additional studies are needed. Results are mixed for asthma management programs. Depression management programs cost more than they save in medical expenses, but may save money when considering productivity outcomes.
format Online
Article
Text
id pubmed-4194913
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher CENTERS for MEDICARE & MEDICAID SERVICES
record_format MEDLINE/PubMed
spelling pubmed-41949132014-11-04 Return on Investment in Disease Management: A Review Goetzel, Ron Z. Ozminkowski, Ronald J. Villagra, Victor G. Duffy, Jennifer Health Care Financ Rev Research Article The results of 44 studies investigating financial impact and return on investment (ROI) from disease management (DM) programs for asthma, congestive heart failure (CHF), diabetes, depression, and multiple illnesses were examined. A positive ROI was found for programs directed at CHF and multiple disease conditions. Some evidence suggests that diabetes programs may save more than they cost, but additional studies are needed. Results are mixed for asthma management programs. Depression management programs cost more than they save in medical expenses, but may save money when considering productivity outcomes. CENTERS for MEDICARE & MEDICAID SERVICES 2005 /pmc/articles/PMC4194913/ /pubmed/17288065 Text en
spellingShingle Research Article
Goetzel, Ron Z.
Ozminkowski, Ronald J.
Villagra, Victor G.
Duffy, Jennifer
Return on Investment in Disease Management: A Review
title Return on Investment in Disease Management: A Review
title_full Return on Investment in Disease Management: A Review
title_fullStr Return on Investment in Disease Management: A Review
title_full_unstemmed Return on Investment in Disease Management: A Review
title_short Return on Investment in Disease Management: A Review
title_sort return on investment in disease management: a review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194913/
https://www.ncbi.nlm.nih.gov/pubmed/17288065
work_keys_str_mv AT goetzelronz returnoninvestmentindiseasemanagementareview
AT ozminkowskironaldj returnoninvestmentindiseasemanagementareview
AT villagravictorg returnoninvestmentindiseasemanagementareview
AT duffyjennifer returnoninvestmentindiseasemanagementareview

Ejemplares similares